Changmao (Dalian) New Material Company Limited, a wholly-owned subsidiary of Changmao Biochemical Engineering Co. Ltd., has entered into a significant sale and leaseback arrangement. On 30 June 2025, Changmao Dalian and its Lessor signed the Sale and Leaseback Agreements, which involve transferring the Leased Assets to the Lessor. This transaction is part of a major financial initiative by the parent company, aimed at optimizing its asset management strategy. The arrangement includes several agreements, such as a finance lease agreement and an ownership transfer agreement. The parent company, Changmao Biochemical Engineering Co. Ltd., is a joint stock limited company incorporated in the People's Republic of China and is publicly listed on the Main Board of the Stock Exchange of Hong Kong.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。